US 9795673
Treating macular degeneration using antibodies to aminophospholipids
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 9795673 (Treating macular degeneration using antibodies to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K39/39558, A61K45/06